Diallyl disulfide increases CDKN1A promoter-associated histone acetylation in human colon tumor cell lines

Nathalie Druesne-Pecollo1, Anthony Pagniez, Muriel Thomas

  • 1Laboratoire de Nutrition et Sécurité Alimentaire, INRA, Domaine de Vilvert, 78352 Jouy-en-Josas cedex, France. Nathalie.Pecollo@jouy.inra.fr

Insights

Diallyl disulfide (DADS), a garlic compound, inhibits colon tumor cell growth by increasing histone acetylation. This epigenetic modification activates CDKN1A gene expression, leading to cell cycle arrest and reduced proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Diallyl disulfide (DADS) is a garlic-derived organosulfur compound with demonstrated anti-proliferative effects on colon tumor cells.
  • Previous research indicated DADS increases histone acetylation and CDKN1A expression, suggesting a role in cell cycle arrest.

Purpose of the Study:

  • To investigate the direct effect of DADS on histone acetylation within the CDKN1A promoter in colon cancer cells.
  • To elucidate the epigenetic mechanisms underlying DADS-induced inhibition of colon tumor cell proliferation.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) assays were performed on Caco-2 and HT-29 colon cancer cell lines.
  • Cells were treated with DADS (200 microM) for 3 and 6 hours.
  • Analysis focused on histone H3 and H4 acetylation levels at the CDKN1A promoter region.

Main Results:

  • DADS treatment significantly increased histone H4 and/or H3 acetylation at the CDKN1A promoter in both cell lines.
  • The observed acetylation changes occurred within 3 to 6 hours of DADS exposure.
  • These findings correlate with previously observed increases in CDKN1A mRNA and p21(waf1) protein.

Conclusions:

  • Histone acetylation of the CDKN1A promoter is a key mechanism by which DADS exerts its anti-proliferative effects in colon tumor cells.
  • Epigenetic regulation via histone acetylation plays a crucial role in DADS-mediated cancer chemoprevention.
  • DADS represents a potential therapeutic agent for colon cancer, acting through modulation of gene expression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...